NSD1 and head and neck squamous cell carcinoma: Intriguingly, HNSCC patients exhibit inactivating NSD1 mutations at a frequency of 10–13%, correlating with a more favorable prognosis, particularly evident in laryngeal subtypes of HPV-negative HNSCC [8,11,12].